Henry VanBrocklin, PhD
Dr. VanBrocklin is the Professor in Residence, Director of the Radiopharmaceutical Research Program in the Center for Molecular and Functional Imaging (CMFI) at the University of California, San Francisco, and he is a Joint Faculty Scientist at the Lawrence Berkeley National Laboratory. He maintains an active radiotracer research program in addition to providing tracers for collaborative basic science and translational clinical research.
Rahul Aggarwal, MD
Dr. Aggarwal is the Professor of Medicine within the Division of Hematology/Oncology at the University of California San Francisco. His clinical research is focused on developing novel therapies and imaging modalities for patients with advanced solid tumor malignancies, with a focus on patients with advanced prostate cancer. He is the Program Leader for GU Medical Oncology program and Associate Director for Clinical Research in the UCSF Helen Diller Family Comprehensive Cancer Center. His clinical research is focused on developing novel therapeutic and imaging strategies for patients with advanced prostate cancer.
Spencer Behr, MD
Dr. Behr is the Associate Professor of Clinical Radiology, Director of the Fellowship for both the Abdominal Imaging subspecialty and for the Department of Radiology and Biomedical Imaging, and Associate Director of Precision Imaging of Cancer and Therapy at the University of California San Francisco. His interests are in translational research in the fields of prostate and the development of novel imaging techniques using PET/CT and PET/MR.
Carolyn Anderson, PhD
Dr. Anderson is the Simon-Ellebracht Professor in Medicinal Chemistry and Professor of Radiology at the University of Missouri. She is a part of the University’s Molecular Imaging and Theranostics Center (MITC). Her research focuses on the design, synthesis, and biological evaluation of novel radiometal-based radiopharmaceuticals for diagnostic imaging and targeted radiotherapy of cancer and other diseases.